Bank of America just raised its EUR/USD forecast
N2OFF, Inc. (NASDAQ:NITO), an agriculture chemicals company with a market capitalization of $2.87 million, has been notified by Nasdaq of non-compliance with the minimum bid price rule. On Monday, the company disclosed receiving a letter from Nasdaq on March 28, 2025, indicating that its common stock, currently trading at $0.25 and down over 80% in the past year according to InvestingPro data, had closed below the required $1.00 per share for 30 consecutive business days.
The current status does not immediately affect N2OFF’s listing, allowing its shares to continue trading on The Nasdaq Capital Market. Despite the price challenges, InvestingPro data shows the company maintains strong liquidity with a current ratio of 6.52 and carries no debt. The company has been granted a 180-day period, until September 24, 2025, to regain compliance with the minimum bid price requirement. Compliance can be achieved if the stock’s closing bid price reaches $1.00 per share for at least ten consecutive business days during this period.
Should N2OFF fail to meet the requirement within the initial 180 days, it may be eligible for an additional 180-day grace period. This extension is contingent upon meeting all other initial listing standards, except for the bid price, and the company’s commitment to address the deficiency through measures such as a reverse stock split.
If the company is unable to restore its compliance with the bid price rule within the given timeframe, including any extensions, it risks having its shares delisted from The Nasdaq Capital Market.
The information provided in this article is based on a press release statement from N2OFF, Inc. For real-time updates and comprehensive analysis of N2OFF’s financial health, including 8 additional key insights and technical indicators, visit InvestingPro.
In other recent news, N2OFF, Inc. has made several strategic moves that could interest investors. The company has amended its investment terms, increasing the ownership cap for certain investors from 4.99% to 9.99% of its outstanding capital stock. This adjustment, part of a Securities Purchase Agreement, allows for greater investor participation without triggering mandatory disclosure requirements. Additionally, N2OFF has extended a $250,000 loan to MitoCareX Bio Ltd., marking its second loan to the company, with an interest rate tied to USD exchange rate fluctuations. The loan supports MitoCareX’s ongoing costs ahead of a pending securities transaction.
N2OFF has also announced the creation of a new subsidiary, NITO Renewable Energy, Inc., to manage its solar energy projects. This move includes ventures in Germany and Italy, with plans for significant solar and battery energy storage projects. Furthermore, N2OFF has reached an agreement to acquire a 70% stake in SB Impact 4 LTD, expanding into the energy storage sector in Italy. Lastly, N2OFF has struck a deal with SciSparc Ltd. to acquire its stake in MitoCareX Bio Ltd., making MitoCareX a wholly owned subsidiary. These recent developments highlight N2OFF’s ongoing efforts to expand its investment and operational footprint in various sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.